<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib80">
 <label>80</label>
 <element-citation publication-type="book" id="sref80">
  <person-group person-group-type="author">
   <name>
    <surname>Alatovic</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <chapter-title>Biontech and Pfizer announce completion of dosing for first cohort of phase 1/2 trial of COVID-19 vaccine candidates in Germany</chapter-title>
  <year>2020</year>
  <publisher-name>Pfizer</publisher-name>
  <comment>April 29. Available from:</comment>
  <ext-link ext-link-type="uri" xlink:href="https://investors.pfizer.com/investor-news/press-release-details/2020/BioNTech-and-Pfizer-announce-completion-of-dosing-for-first-cohort-of-Phase-1-2-trial-of-COVID-19-vaccine-candidates-in-Germany/default.aspx" id="intref0175" xmlns:xlink="http://www.w3.org/1999/xlink">https://investors.pfizer.com/investor-news/press-release-details/2020/BioNTech-and-Pfizer-announce-completion-of-dosing-for-first-cohort-of-Phase-1-2-trial-of-COVID-19-vaccine-candidates-in-Germany/default.aspx</ext-link>
 </element-citation>
</ref>
